Bill Colston

Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research … To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted and repeatable insights that transform scientific discoveries into better outcomes • Improving operating systems through more focused, methodical and consistent processes and an emphasis on quality • Delivering important value to our customers and their research

Purigen Biosystems provides innovative products that offer a truly transformative solution for DNA and RNA purification. Our proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, our technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Our Ionic® Purification System and Kits combine to provide researchers with a fast, efficient and effective alternative for automated nucleic acid purification.

Rheonix, Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. As scientific knowledge evolves, so does the need for new diagnostic technology to simplify processes and enhance innovation. Rheonix, through experienced leadership and creative vision, has developed the Encompass platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD® cartridge. With both the Rheonix CARD and Encompass family of products, Rheonix is well-positioned to penetrate key molecular diagnostic market sectors, from reference labs through point-of-care and everywhere in-between.

We're excited to be part of the larger team at Inscripta, Inc! You can visit us at www.inscripta.com and learn more about the acquisition at https://www.inscripta.com/news/inscripta-acquires-infinome-biosciences-and-sestina-bio

Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research … To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted and repeatable insights that transform scientific discoveries into better outcomes • Improving operating systems through more focused, methodical and consistent processes and an emphasis on quality • Delivering important value to our customers and their research

Purigen Biosystems provides innovative products that offer a truly transformative solution for DNA and RNA purification. Our proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, our technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Our Ionic® Purification System and Kits combine to provide researchers with a fast, efficient and effective alternative for automated nucleic acid purification.

Rheonix, Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. As scientific knowledge evolves, so does the need for new diagnostic technology to simplify processes and enhance innovation. Rheonix, through experienced leadership and creative vision, has developed the Encompass platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD® cartridge. With both the Rheonix CARD and Encompass family of products, Rheonix is well-positioned to penetrate key molecular diagnostic market sectors, from reference labs through point-of-care and everywhere in-between.

HealthTell, Inc. is developing next generation immune profiling assays that broadly characterize the immune system, serving as a platform technology for the biopharmaceutical, search and clinical communities. The technology uses a proprietary immune profiling technology to analyze the immune system’s response against disease – with unprecedented depth and specificity. With applications in drug target discovery, monoclonal antibody characterization, and disease monitoring and therapeutic response, HealthTell will shed new light on important diseases such as autoimmune, cancer, CNS, and infectious disease. HealthTell operates a state-of-the-art high throughput centralized laboratory in San Ramon, CA that supports clients in biopharmaceuticals, and research collaborators.